Cargando…
A pan-tumor-siRNA aptamer chimera to block nonsense-mediated mRNA decay inflames and suppresses tumor progression
Immune-checkpoint blockade (ICB) therapy has changed the clinical outcome of many types of aggressive tumors, but there still remain many cancer patients that do not respond to these treatments. There is an unmet need to develop a feasible clinical therapeutic platform to increase the rate of respon...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379514/ https://www.ncbi.nlm.nih.gov/pubmed/35991316 http://dx.doi.org/10.1016/j.omtn.2022.07.017 |
_version_ | 1784768691109363712 |
---|---|
author | Meraviglia-Crivelli, Daniel Villanueva, Helena Menon, Ashwathi Puravankara Zheleva, Angelina Moreno, Beatriz Villalba-Esparza, María Pastor, Fernando |
author_facet | Meraviglia-Crivelli, Daniel Villanueva, Helena Menon, Ashwathi Puravankara Zheleva, Angelina Moreno, Beatriz Villalba-Esparza, María Pastor, Fernando |
author_sort | Meraviglia-Crivelli, Daniel |
collection | PubMed |
description | Immune-checkpoint blockade (ICB) therapy has changed the clinical outcome of many types of aggressive tumors, but there still remain many cancer patients that do not respond to these treatments. There is an unmet need to develop a feasible clinical therapeutic platform to increase the rate of response to ICB. Here we use a previously described clinically tested aptamer (AS1411) conjugated with SMG1 RNAi (AS1411-SMG1 aptamer-linked siRNA chimeras [AsiCs]) to inhibit the nonsense-mediated RNA decay pathway inducing tumor inflammation and improving response to ICB. The aptamer AS1411 shows binding to numerous mouse and human tumor cell lines tested. AS1411 induces tumor cytotoxicity in long incubation times, which allows for the use of the aptamer as a carrier to target the RNAi inhibition to the tumor. The AS1411-SMG1 AsiCs induce a strong antitumor response in local and systemic treatment in different types of tumors. Finally, AS1411-SMG1 AsiCs are well tolerated with no detected side effects. |
format | Online Article Text |
id | pubmed-9379514 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Society of Gene & Cell Therapy |
record_format | MEDLINE/PubMed |
spelling | pubmed-93795142022-08-18 A pan-tumor-siRNA aptamer chimera to block nonsense-mediated mRNA decay inflames and suppresses tumor progression Meraviglia-Crivelli, Daniel Villanueva, Helena Menon, Ashwathi Puravankara Zheleva, Angelina Moreno, Beatriz Villalba-Esparza, María Pastor, Fernando Mol Ther Nucleic Acids Original Article Immune-checkpoint blockade (ICB) therapy has changed the clinical outcome of many types of aggressive tumors, but there still remain many cancer patients that do not respond to these treatments. There is an unmet need to develop a feasible clinical therapeutic platform to increase the rate of response to ICB. Here we use a previously described clinically tested aptamer (AS1411) conjugated with SMG1 RNAi (AS1411-SMG1 aptamer-linked siRNA chimeras [AsiCs]) to inhibit the nonsense-mediated RNA decay pathway inducing tumor inflammation and improving response to ICB. The aptamer AS1411 shows binding to numerous mouse and human tumor cell lines tested. AS1411 induces tumor cytotoxicity in long incubation times, which allows for the use of the aptamer as a carrier to target the RNAi inhibition to the tumor. The AS1411-SMG1 AsiCs induce a strong antitumor response in local and systemic treatment in different types of tumors. Finally, AS1411-SMG1 AsiCs are well tolerated with no detected side effects. American Society of Gene & Cell Therapy 2022-07-20 /pmc/articles/PMC9379514/ /pubmed/35991316 http://dx.doi.org/10.1016/j.omtn.2022.07.017 Text en © 2022 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Original Article Meraviglia-Crivelli, Daniel Villanueva, Helena Menon, Ashwathi Puravankara Zheleva, Angelina Moreno, Beatriz Villalba-Esparza, María Pastor, Fernando A pan-tumor-siRNA aptamer chimera to block nonsense-mediated mRNA decay inflames and suppresses tumor progression |
title | A pan-tumor-siRNA aptamer chimera to block nonsense-mediated mRNA decay inflames and suppresses tumor progression |
title_full | A pan-tumor-siRNA aptamer chimera to block nonsense-mediated mRNA decay inflames and suppresses tumor progression |
title_fullStr | A pan-tumor-siRNA aptamer chimera to block nonsense-mediated mRNA decay inflames and suppresses tumor progression |
title_full_unstemmed | A pan-tumor-siRNA aptamer chimera to block nonsense-mediated mRNA decay inflames and suppresses tumor progression |
title_short | A pan-tumor-siRNA aptamer chimera to block nonsense-mediated mRNA decay inflames and suppresses tumor progression |
title_sort | pan-tumor-sirna aptamer chimera to block nonsense-mediated mrna decay inflames and suppresses tumor progression |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9379514/ https://www.ncbi.nlm.nih.gov/pubmed/35991316 http://dx.doi.org/10.1016/j.omtn.2022.07.017 |
work_keys_str_mv | AT meravigliacrivellidaniel apantumorsirnaaptamerchimeratoblocknonsensemediatedmrnadecayinflamesandsuppressestumorprogression AT villanuevahelena apantumorsirnaaptamerchimeratoblocknonsensemediatedmrnadecayinflamesandsuppressestumorprogression AT menonashwathipuravankara apantumorsirnaaptamerchimeratoblocknonsensemediatedmrnadecayinflamesandsuppressestumorprogression AT zhelevaangelina apantumorsirnaaptamerchimeratoblocknonsensemediatedmrnadecayinflamesandsuppressestumorprogression AT morenobeatriz apantumorsirnaaptamerchimeratoblocknonsensemediatedmrnadecayinflamesandsuppressestumorprogression AT villalbaesparzamaria apantumorsirnaaptamerchimeratoblocknonsensemediatedmrnadecayinflamesandsuppressestumorprogression AT pastorfernando apantumorsirnaaptamerchimeratoblocknonsensemediatedmrnadecayinflamesandsuppressestumorprogression AT meravigliacrivellidaniel pantumorsirnaaptamerchimeratoblocknonsensemediatedmrnadecayinflamesandsuppressestumorprogression AT villanuevahelena pantumorsirnaaptamerchimeratoblocknonsensemediatedmrnadecayinflamesandsuppressestumorprogression AT menonashwathipuravankara pantumorsirnaaptamerchimeratoblocknonsensemediatedmrnadecayinflamesandsuppressestumorprogression AT zhelevaangelina pantumorsirnaaptamerchimeratoblocknonsensemediatedmrnadecayinflamesandsuppressestumorprogression AT morenobeatriz pantumorsirnaaptamerchimeratoblocknonsensemediatedmrnadecayinflamesandsuppressestumorprogression AT villalbaesparzamaria pantumorsirnaaptamerchimeratoblocknonsensemediatedmrnadecayinflamesandsuppressestumorprogression AT pastorfernando pantumorsirnaaptamerchimeratoblocknonsensemediatedmrnadecayinflamesandsuppressestumorprogression |